These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28955188)

  • 41. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy.
    Rozanski A; Blumenthal JA; Kaplan J
    Circulation; 1999 Apr; 99(16):2192-217. PubMed ID: 10217662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Social behavior and gender in biomedical investigations using monkeys: studies in atherogenesis.
    Kaplan JR; Adams MR; Clarkson TB; Manuck SB; Shively CA
    Lab Anim Sci; 1991 Aug; 41(4):334-43. PubMed ID: 1658480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the "timing hypothesis".
    Sowers MR; Randolph J; Jannausch M; Lasley B; Jackson E; McConnell D
    Arch Intern Med; 2008 Oct; 168(19):2146-53. PubMed ID: 18955645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Southwestern Internal Medicine Conference: postmenopausal estrogen supplementation: a cardiologist's perspective.
    Radford NB
    Am J Med Sci; 1994 Jul; 308(1):63-73. PubMed ID: 8010341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women.
    Contreras I; Parra D
    Am J Health Syst Pharm; 2000 Nov; 57(21):1963-8; quiz 1969-71. PubMed ID: 11094650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular effects of endogenous estrogen and hormone therapy.
    Bechlioulis A; Naka KK; Calis KA; Makrigiannakis A; Michalis L; Kalantaridou SN
    Curr Vasc Pharmacol; 2010 Mar; 8(2):249-58. PubMed ID: 19485910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Flow mediated vasodilation compared with carotid intima media thickness in the evaluation of early cardiovascular damage in menopausal women and the influence of biological and psychosocial factors.
    Sanchez-Barajas M; Ibarra-Reynoso LDR; Ayala-Garcia MA; Malacara JM
    BMC Womens Health; 2018 Sep; 18(1):153. PubMed ID: 30236100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evolving issues in the clinical and managed care settings on the management of menopause following the women's health initiative.
    Lukes A
    J Manag Care Pharm; 2008 Apr; 14(3 Suppl):7-13. PubMed ID: 18439061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Women, the menopause, hormone replacement therapy and coronary heart disease.
    Whayne TF; Mukherjee D
    Curr Opin Cardiol; 2015 Jul; 30(4):432-8. PubMed ID: 25695898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determinants of coronary artery reactivity in premenopausal female cynomolgus monkeys with diet-induced atherosclerosis.
    Williams JK; Shively CA; Clarkson TB
    Circulation; 1994 Aug; 90(2):983-7. PubMed ID: 8044971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Menopausal status influences ambulatory blood pressure levels and blood pressure changes during mental stress.
    Owens JF; Stoney CM; Matthews KA
    Circulation; 1993 Dec; 88(6):2794-802. PubMed ID: 8252693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hormone replacement therapy and the association with coronary heart disease and overall mortality: clinical application of the timing hypothesis.
    Hodis HN; Mack WJ
    J Steroid Biochem Mol Biol; 2014 Jul; 142():68-75. PubMed ID: 23851166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications.
    Vogelvang TE; van der Mooren MJ; Mijatovic V
    Treat Endocrinol; 2004; 3(2):105-15. PubMed ID: 15743106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries.
    Wildman RP; Schott LL; Brockwell S; Kuller LH; Sutton-Tyrrell K
    J Am Coll Cardiol; 2004 Aug; 44(3):579-85. PubMed ID: 15358024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen.
    Lindheim SR; Legro RS; Bernstein L; Stanczyk FZ; Vijod MA; Presser SC; Lobo RA
    Am J Obstet Gynecol; 1992 Dec; 167(6):1831-6. PubMed ID: 1471706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis: The Tromsø Study.
    Joakimsen O; Bønaa KH; Stensland-Bugge E; Jacobsen BK
    J Clin Epidemiol; 2000 May; 53(5):525-30. PubMed ID: 10812326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical review: Cardiovascular consequences of ovarian disruption: a focus on functional hypothalamic amenorrhea in physically active women.
    O'Donnell E; Goodman JM; Harvey PJ
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3638-48. PubMed ID: 21956422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controversies about HRT--lessons from monkey models.
    Clarkson TB; Appt SE
    Maturitas; 2005 May; 51(1):64-74. PubMed ID: 15883111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of estrogens in cardiovascular disease in the aftermath of clinical trials.
    Gouva L; Tsatsoulis A
    Hormones (Athens); 2004; 3(3):171-83. PubMed ID: 16982590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.